Congress is poised to pass Project Mend, a revolutionary AI gene-editing program promising to cure disease and extend human life. Hidden deep in the bill is a darker truth: the first full-scale human trials will be conducted only on incarcerated 
 
Foundational Black Americans—a chilling twenty-first-century echo of the Tuskegee experiment.
Fresh from exposing stolen genius in The Dark Lady and Taste & Entitlement, investigator-scholar Naomi Reed uncovers the secret draft of the Genomic Realignment Act and recognizes a familiar pattern of exploitation—now weaponized with futuristic science.
 
Her investigation uncovers a global conspiracy:
Mend’s AI isn’t just healing DNA—it’s rewriting ancestral traits, from pigmentation to memory-linked epigenetics.
Volunteers are lifers offered a brutal choice: survive and walk free—or die with the 69 percent projected mortality curve.
Corporate backers in pharma and Silicon Valley see a trillion-dollar health market.
 
From Washington’s marble corridors to covert desert labs and hidden gene banks in Ghana, Naomi follows a trail of hacked DNA records, assassinations staged as overdoses, and high-tech sabotage.
 
Then the mission turns personal: her estranged father, a lifer himself, has volunteered for the trial—his only chance at freedom if he survives the procedure’s lethal odds. Exposing the program could save thousands, but destroy her father’s last hope.
 
As Congress races toward a historic vote and protests ignite across the globe, Naomi must infiltrate a fortified genomic facility to stop a technology that could rewrite what it means to be human.
The breathtaking finale to the Naomi Reed trilogy, The Genomic Realignment Act is a speculative thriller where science, politics, and race collide—and where the future of Black life hangs in the balance.